An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION)
Clinical trial NCT03699449 · UNKNOWN
Trial details
- NCT number
- NCT03699449
- Sponsor
- Yonsei University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-26
- Primary completion
- 2022-09-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.